Advancing Science. Connecting Disciplines. Shaping the Future of Neurodegenerative Research.
The mission of AD/PD™ is to accelerate progress in understanding, preventing, and treating Alzheimer’s, Parkinson’s, and related neurodegenerative diseases by fostering global collaboration across disciplines.
Since its founding, AD/PD™ has been guided by a singular vision: to bring together scientists and clinicians who traditionally work in separate fields and create a unified platform for discovery. By examining both the shared mechanisms and distinct characteristics of neurodegenerative diseases, the conference drives a more comprehensive and impactful approach to research.
What We Stand For
Scientific Excellence
Delivering a high-quality, cutting-edge program that showcases the latest advances in basic science, translational research, and clinical practice, from disease mechanisms to diagnostics, prevention, and therapy.
Multidisciplinary Collaboration
Uniting a global community of experts across diverse specialties, including clinicians, basic scientists, and industry leaders, to encourage cross-disciplinary dialogue and innovation.
Global Knowledge Exchange
Providing a premier international platform where breakthrough discoveries are first presented, discussed, and refined through open scientific exchange.
Support for the Next Generation
Empowering early-career researchers through dedicated initiatives, including awards and opportunities to present, connect, and grow within the global scientific community.
An Environment for Interaction
Creating a uniquely collegial and interactive atmosphere that promotes meaningful dialogue, networking, and long-term collaboration.
Our Commitment
AD/PD™ remains committed to advancing science and therapy in neurodegenerative diseases while strengthening the global research community. As the field evolves, so does our responsibility to provide a platform that not only reflects the latest scientific progress but actively shapes it.
Striving for a better future for all those affected by neurodegenerative diseases.